Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: A survey of health plans

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 12, 2008, Pages 1137-1141

  Moore, Kristen M ^a,b   Duddy, April ^a,b   Braun, M Miles ^c   Platt, Richard ^a,b   Brown, Jeffrey S ^a,b  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b HMO Research Network Center for Education and Research in Therapeutics   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse event detection; Distributed data network; Pandemic influenza vaccine

Indexed keywords

INFLUENZA VACCINE;

ADMINISTRATIVE PERSONNEL; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; FINANCIAL MANAGEMENT; HEALTH CARE PLANNING; HEALTH INSURANCE; INTERVIEW; MEDICAL INFORMATION SYSTEM; ORGANIZATIONAL DEVELOPMENT; ORGANIZATIONAL EFFICIENCY; PANDEMIC; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK MANAGEMENT; UNITED STATES; COOPERATION; DECISION MAKING; ECONOMICS; EPIDEMIC; FACTUAL DATABASE; FOOD AND DRUG ADMINISTRATION; HEALTH SURVEY; HUMAN; INFLUENZA; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COOPERATIVE BEHAVIOR; DATABASES, FACTUAL; DECISION MAKING; DISEASE OUTBREAKS; HEALTH PLANNING; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INSURANCE, HEALTH; POPULATION SURVEILLANCE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 59649128107     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1642     Document Type: Article

References (15)

1. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. U.S. Food and Drug Administration, 2007. www.fda.gov/bbs/ topics/news/2007/new01611.html [Accessed 6 February 2008].
2. Committee on the Assessment of the US Drug Safety System. The Future of Drug Safety: Promoting and Protecting the Health of the Public. Washington, DC: Institute of Medicine of the National Academies, 2006.
3. Centers for Disease Control and Prevention. Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999; 48(43): 1007.
4. Piazza-Hepp TD, Kennedy DL. Reporting of adverse events to MedWatch. Am J Health Syst Pharm 1995; 52(13): 1436-1439.
5. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 1999; 281(9): 824-829.
6. Centers for Disease Control and Prevention. Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep 2008; 57(10): 258-260.
7. Lieu TA, Kulldorff M, Davis RL, et al. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007; 45(10): S89-S95.
8. Davis RL, Kolczak M, Lewis E, et al. Active surveillance of vaccine safety: a system to detect early signs of adverse events. Epidemiology 2005; 16(3): 336-341.
9. Vaccine Safety Datalink (VSD) Project. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccinesafety/vsd/ [Accessed 4 February 2008].
10. Lazarus R, Yih K, Platt R. Distributed data processing for public health surveillance. BMC Public Health 2006; 6: 235.
11. Drake TA, Braun J, Marchevsky A, et al. A system for sharing routine surgical pathology specimens across institutions: the Shared Pathology Informatics Network. Hum Pathol 2007; 38(8): 1212-1225.
12. McMurry AJ, Gilbert CA, Reis BY, Chueh HC, Kohane IS, Mandl KD. A self-scaling, distributed information architecture for public health, research, and clinical care. J Am Med Inform Assoc 2007; 14(4): 527-533.
13. Food and Drug Administration Amendments Act of 2007, Public Law 110-85 (HR 3580), 110th Congress, 1st session (September 27, 2007).
14. The Sentinel Initiative: National Strategy for Monitoring Medical Product Safety. U.S. Food and Drug Administration, 2008. (Accessed at http://www.fda.gov/oc/initiatives/advance/reports/report0508.html).
15. Safety study of GBS following Menactra meningococcal vaccination (NCT00575653). In National Institutes of Health (NIH) Clinical Trials Registry, 2007. www.clincialtrials.gov